Market Cap 404.05M
Revenue (ttm) 0.00
Net Income (ttm) -46.38M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 858,800
Avg Vol 1,701,050
Day's Range N/A - N/A
Shares Out 92.67M
Stochastic %K 68%
Beta 1.21
Analysts Sell
Price Target $22.00

Company Profile

Anavex Life Sciences Corp. operates as a biopharmaceutical company. It engages in developing innovative treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders, pain, and various types of cancer . Its lead drug candidate, ANAVEX 2-73 (blarcamesine), has completed a Phase 2a and a Phase 2b/3 clinical trial for Alzheimer's disease; a Phase 2 proof-of-c...

Industry: Biotechnology
Sector: Healthcare
Phone: 844 689 3939
Address:
630 5th Avenue, 20th Floor, New York, United States
pedmac2000
pedmac2000 Feb. 27 at 1:17 AM
$AVXL good lesson in trading
0 · Reply
Georgejj
Georgejj Feb. 27 at 1:16 AM
$AVXL Anavex Life Sciences Appoints Dr. Axel Paeger, MD, MBA, MBI To Board https://www.citybiz.co/article/809296/anavex-life-sciences-appoints-dr-axel-paeger-md-mba-mbi-to-board/ Dr. Paeger is a seasoned leader in healthcare with over 30 years of experience in running inpatient medical care. Dr. Paeger currently serves as Chief Executive Officer of the AMEOS Group, headquartered in Zürich, Switzerland, which is today among the leading healthcare providers in Europe. The AMEOS Group owns and runs 85 hospitals and polyclinics and additionally 23 long-term elderly care and long-term mental care facilities. 19,300 employees serve about half a million patients per year. While the AMEOS Group generates about one third of its revenues from its psychiatric hospitals, it is the market leader in psychiatric inpatient care in the DACH (Germany, Austria, Switzerland) region, a region in Europe with a combined GDP approaching $6 trillion. The AMEOS Group is also a major provider of inpatient neurological care. Good luck and GOD bless,
0 · Reply
TTTav66
TTTav66 Feb. 26 at 11:30 PM
$AVXL Anavex is currently both a sponsor and an attendee at the Global Alzheimer’s Platform Foundation Conference in Las Vegas, Feb 25-27. https://globalalzplatform.org/2026/02/20/leading-alzheimers-experts-to-convene-in-las-vegas-at-international-clinical-research-conference/ About GAP: https://globalalzplatform.org/
2 · Reply
old_salt
old_salt Feb. 26 at 9:07 PM
$AVXL 💪
0 · Reply
Logic102
Logic102 Feb. 26 at 8:59 PM
$AVXL Growing consensus that the costly, inconvenient, risky mAbs are not making any positive real-life effect for patients and families. The Risk Reward sucks. Downstream attempts will fail. Upstream methods of action are the Way the Truth and the Light.
0 · Reply
gldncrss
gldncrss Feb. 26 at 8:00 PM
$AVXL looks like we keep hitting short stop losses, idk for sure but it’s very calculated and timed for now
2 · Reply
Brian5220
Brian5220 Feb. 26 at 7:27 PM
$AVXL Yet another report that Donanemab doesn't work... Seems to be an unmet need for Alzheimer's... hmmm. Blarcamesine! 👍 https://www.linkedin.com/posts/dylan-williams-a5319389_no-evidence-for-cognitive-benefits-from-reducing-share-7432476695665963008-XQak?utm_source=share&utm_medium=member_desktop&rcm=ACoAAE1L2XABRThjdy3Ll5bTXpQ-1T2bQt5kAMU
1 · Reply
gldncrss
gldncrss Feb. 26 at 6:00 PM
$AVXL can’t wait for the legion of boom😂🫣
0 · Reply
bartwood
bartwood Feb. 26 at 4:32 PM
0 · Reply
gldncrss
gldncrss Feb. 26 at 4:21 PM
$AVXL I mean it is technically financial terrorism
1 · Reply
Latest News on AVXL
Anavex Life Sciences Corp. (AVXL) Q4 2025 Earnings Call Transcript

Nov 25, 2025, 11:53 AM EST - 3 months ago

Anavex Life Sciences Corp. (AVXL) Q4 2025 Earnings Call Transcript


Anavex Life Sciences Corp. (AVXL) Q3 2025 Earnings Call Transcript

Aug 12, 2025, 10:38 AM EDT - 7 months ago

Anavex Life Sciences Corp. (AVXL) Q3 2025 Earnings Call Transcript


Does Anavex's Alzheimer's Drug Actually Confer Benefit?

May 15, 2025, 8:49 PM EDT - 10 months ago

Does Anavex's Alzheimer's Drug Actually Confer Benefit?


Anavex Life Sciences Corp. (AVXL) Q2 2025 Earnings Call Transcript

May 13, 2025, 9:25 AM EDT - 10 months ago

Anavex Life Sciences Corp. (AVXL) Q2 2025 Earnings Call Transcript


pedmac2000
pedmac2000 Feb. 27 at 1:17 AM
$AVXL good lesson in trading
0 · Reply
Georgejj
Georgejj Feb. 27 at 1:16 AM
$AVXL Anavex Life Sciences Appoints Dr. Axel Paeger, MD, MBA, MBI To Board https://www.citybiz.co/article/809296/anavex-life-sciences-appoints-dr-axel-paeger-md-mba-mbi-to-board/ Dr. Paeger is a seasoned leader in healthcare with over 30 years of experience in running inpatient medical care. Dr. Paeger currently serves as Chief Executive Officer of the AMEOS Group, headquartered in Zürich, Switzerland, which is today among the leading healthcare providers in Europe. The AMEOS Group owns and runs 85 hospitals and polyclinics and additionally 23 long-term elderly care and long-term mental care facilities. 19,300 employees serve about half a million patients per year. While the AMEOS Group generates about one third of its revenues from its psychiatric hospitals, it is the market leader in psychiatric inpatient care in the DACH (Germany, Austria, Switzerland) region, a region in Europe with a combined GDP approaching $6 trillion. The AMEOS Group is also a major provider of inpatient neurological care. Good luck and GOD bless,
0 · Reply
TTTav66
TTTav66 Feb. 26 at 11:30 PM
$AVXL Anavex is currently both a sponsor and an attendee at the Global Alzheimer’s Platform Foundation Conference in Las Vegas, Feb 25-27. https://globalalzplatform.org/2026/02/20/leading-alzheimers-experts-to-convene-in-las-vegas-at-international-clinical-research-conference/ About GAP: https://globalalzplatform.org/
2 · Reply
old_salt
old_salt Feb. 26 at 9:07 PM
$AVXL 💪
0 · Reply
Logic102
Logic102 Feb. 26 at 8:59 PM
$AVXL Growing consensus that the costly, inconvenient, risky mAbs are not making any positive real-life effect for patients and families. The Risk Reward sucks. Downstream attempts will fail. Upstream methods of action are the Way the Truth and the Light.
0 · Reply
gldncrss
gldncrss Feb. 26 at 8:00 PM
$AVXL looks like we keep hitting short stop losses, idk for sure but it’s very calculated and timed for now
2 · Reply
Brian5220
Brian5220 Feb. 26 at 7:27 PM
$AVXL Yet another report that Donanemab doesn't work... Seems to be an unmet need for Alzheimer's... hmmm. Blarcamesine! 👍 https://www.linkedin.com/posts/dylan-williams-a5319389_no-evidence-for-cognitive-benefits-from-reducing-share-7432476695665963008-XQak?utm_source=share&utm_medium=member_desktop&rcm=ACoAAE1L2XABRThjdy3Ll5bTXpQ-1T2bQt5kAMU
1 · Reply
gldncrss
gldncrss Feb. 26 at 6:00 PM
$AVXL can’t wait for the legion of boom😂🫣
0 · Reply
bartwood
bartwood Feb. 26 at 4:32 PM
0 · Reply
gldncrss
gldncrss Feb. 26 at 4:21 PM
$AVXL I mean it is technically financial terrorism
1 · Reply
gldncrss
gldncrss Feb. 26 at 4:20 PM
$AVXL sure would be nice if trump would declare naked short selling a threat to our national security and our economy
0 · Reply
Stoneage823
Stoneage823 Feb. 26 at 3:55 PM
$AVXL 💪💪🤑🤑
0 · Reply
Georgejj
Georgejj Feb. 26 at 3:53 PM
$AVXL Dork just posts lies and FUD about AVXL!!!
1 · Reply
zigsfrd
zigsfrd Feb. 26 at 3:05 PM
$AVXL Doc Dork's research department has alot more resources to do DD on this company than the 45% institutional ownership ever hope to have. Why don't you people just listen.😂😂😂
1 · Reply
DrocDolf
DrocDolf Feb. 26 at 2:46 PM
$AVXL It was indeed a sharp decline, and those who shorted it were right! It's much easier now, with the EMA's strong rejection confirming the thesis.
0 · Reply
PharmaBro2
PharmaBro2 Feb. 26 at 2:45 PM
$AVXL short the stock and buy call is the strategy here. options are very cheap. say you have 5k. short stock using 4K. buy 1K worth of june $8 -10 call (50) . if approval sp will be $20. you lost your 4k short position . but your 1k worth of call will be 40-50K. now if it gets rejected sp will be on $1.5-2. you make 2.5 k but lost 1k on call option.
1 · Reply
old_salt
old_salt Feb. 26 at 2:13 PM
0 · Reply
papatrick
papatrick Feb. 26 at 2:03 PM
$AVXL is it the 5$ return day? I think so based on yesterday peak. A peak at 5.2 at least...followed by usual deflation and shorts control. Till re exam news, expect volatility increase toward a return to double digit while shorts are covering massively
1 · Reply
papatrick
papatrick Feb. 26 at 2:00 PM
$AVXL Life will not give you another chance like this. First i see at least 90% odds of approval, second, the news will pr9bably be with a market closed or halted, and it will re open at 10 times SP...so you will just have missed the main part of the gain
1 · Reply
Bbboston
Bbboston Feb. 26 at 1:44 PM
$AVXL Casinos give you the same 50/50 odds. This is not investment, this is simple gambling. I rather wait for approval and then buy! I take less profit but take out most of the risk at that price level.
3 · Reply
Rudedog_1963
Rudedog_1963 Feb. 26 at 1:07 PM
0 · Reply
Woundntyouliketoknow
Woundntyouliketoknow Feb. 26 at 12:38 PM
$AVXL Latest short interest for AVXL - Slight increase 02/13/2026 20,532,909 01/30/2026 19,953,236 Source: https://www.nasdaq.com/market-activity/stocks/avxl/short-interest
2 · Reply